Groupe Pharmaceutique Duchesnay donates medicines and vitamins made in Quebec to Ukraine to help people affected by the war


Content of the article

The company is also opening new positions at its Blainville offices to refugee candidates from Ukraine or elsewhere.

Advertisement 2

Content of the article

BLAINVILLE, Quebec, April 27, 2022 (GLOBE NEWSWIRE) — Duchesnay Pharmaceutical Group has donated a large amount of prescription prenatal medications and vitamins produced at its manufacturing facility in Blainville, Quebec, to help affected Ukrainians by devastating war.

A total of ten pallets of Duchesnay products were shipped from Blainville to the organization Collaboration Santé Internationale (CSI), based in Quebec, which coordinates the delivery of products and other medical materials donated to Ukraine via its vast network.

The medicines donated are intended to help more than 22,000 women and new mothers. They include the vitamin-mineral supplements PregVit® for prenatal and postpartum use and Pregvit Folic 5® for prenatal use, as well as Diclectin® (delayed-release tablets of doxylamine succinate and pyridoxine hydrochloride), indicated for the management of burden of nausea and vomiting of pregnancy.

Advertisement 3

Content of the article

In addition, Duchesnay has also posted a number of new positions at its Blainville offices on federal government and Quebec government employment sites for which it seeks to hire Ukrainian refugees recently arrived in Canada or refugees from other countries. The positions were made available and necessary due to the continued growth of the company’s manufacturing activities in Blainville.

“Duchesnay is very pleased to be able to support the Ukrainian people with this donation of medicines made in Quebec and to open new full-time positions in our manufacturing plant to Ukrainian or other refugees who have recently arrived in Canada,” said Éric Gervais. . , President, Duchesnay Pharmaceutical Group. “As a growing multinational Quebec company, we believe it is our responsibility to help and give back when we can, and this is certainly an occasion when the Ukrainian people need the help of the whole world.

Advertisement 4

Content of the article

“We sincerely thank Duchesnay Pharmaceutical Group for their generosity which allows us to increase the volume and variety of much-needed medicines and medical supplies we send to the Ukrainian people,” said Jacques Paradis, CEO of CSI. “This important donation, as well as the other monetary and material donations we have received, clearly demonstrate the solidarity of our companies in Quebec. Duchesnay’s donation will soon leave by plane to help several NGOs specializing in emergency care with whom we are in dialogue and who work directly with Ukrainian refugees.

About International Health Collaboration (CSI)
Since 1968, CSI has been meeting the demands of healthcare professionals working in developing countries by supplying them with high quality medicines and medical equipment. Since 1996, the CSI has been the only international cooperation organization accredited by the Quebec Ministry of Health and Social Services to receive and distribute, for humanitarian purposes, surplus drugs and equipment from Quebec health institutions. Each year, CSI collects, verifies and redistributes approximately 300 tons of these items to approximately 50 health centers in developing countries around the world. To see here for more details.

Advertisement 5

Content of the article

About the Duchesnay Pharmaceutical Group
The Duchesnay Pharmaceutical Group, together with its affiliated companies, has its head office in Blainville, Quebec. The group is made up of five pharmaceutical companies to meet the needs of patients in Canada, the United States and abroad. The companies are Duchesnay and Duchesnay USA, both dedicated to women’s health; Médunik Canada and Médunik USA, which offer treatments for rare diseases; and Analog Pharma, an American generic drug company, specializing in authorized generics and orphan drugs. From its state-of-the-art manufacturing plant, Duchesnay can export its innovative treatments to more than 50 countries.

Duchesnay and Médunik, through their exclusive research and development and through partnerships, offer innovative treatments for a variety of medical conditions in women’s health, urology, oncology and rare diseases. The group of companies recognizes the dedication and professionalism of its employees and promotes a positive culture and a flexible working environment. He is deeply committed to environmental responsibility and giving back to the community through the support of various charities. For more information, please visit, and

Media contact for Duchesnay interview requests:
Sabrina Sevigny
Tel: (514) 991-4148
E-mail: [email protected]

Media contact for CSI
Veronique Jampierre
Tel: (418) 561-7860
E-mail: [email protected]

A photo accompanying this ad is available at



Postmedia is committed to maintaining a lively yet civil discussion forum and encourages all readers to share their views on our articles. Comments can take up to an hour to be moderated before appearing on the site. We ask that you keep your comments relevant and respectful. We have enabled email notifications. You will now receive an email if you receive a reply to your comment, if there is an update to a comment thread you follow, or if a user follows you comments. Visit our Community Rules for more information and details on how to adjust your E-mail settings.


About Author

Comments are closed.